Aarti Pharmalabs Limited

Web: aartipharmalabs.com NSE: AARTIPHARM BSE: 543748 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

832 1(0%)

Volume

18L as on 23, Jun

Open

573

High

580

Low

572

832

VWAP

712

52 Week High

1,002

52 Week Low

585

Viand Research Rating

Quality Score

53/100

Growth Score

37/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

7,540

No. of Shares

9.07

P/E

27.47

P/B

3.32

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.08

ROCE

Profit Growth

Listing Date

30-Jan-23

Rank/Sector Rank

#664/#63

Promoter Holding

42.86%

FII Holding

8.17%

DII Holding

7.22%

Price Chart

Price Performance

1 Week11%

1 Month0%

3 Months15%

6 Months3%

1 Year3%

YTD3%

Moving Average

5 Day SMA677

10 Day SMA655

20 Day SMA647

30 Day SMA668

50 Day SMA690

61 Day SMA681

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	719	685	709	719
Resistance 2	709	683	699	709
Resistance 1	693	680	693	693
Pivot Point	684	678	684	684
Support 1	668	676	674	668
Support 2	658	673	668	658
Support 3	643	671	658	643

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Promoters	(-0.21) 42.86%	(0.01) 43.08%	(0.21) 43.10%	(-0.81) 42.88%	(-0.61) 43.72%	(-0.41) 44.29%	(-1.51) 44.65%	(-0.41) 46.10%	(0.01) 46.46%	(0.01) 46.46%	(0.21) 46.46%	(0.31) 46.30%	(0.01) 45.98%	(0.01) 45.98%
FIIs	(-0.21) 8.17%	(0.71) 8.39%	(-0.31) 7.69%	(0.71) 8.02%	(0.01) 7.34%	(-1.31) 7.36%	(1.31) 8.64%	(0.31) 7.38%	(-1.31) 7.07%	(0.21) 8.33%	(-0.31) 8.17%	(1.01) 8.45%	(-0.31) 7.43%	(0.01) 7.69%
DIIs	(-0.21) 7.22%	(-0.31) 7.40%	(0.71) 7.66%	(-0.91) 6.95%	(0.31) 7.80%	(-2.81) 7.53%	(-1.01) 10.36%	(-0.11) 11.35%	(1.51) 11.47%	(0.11) 9.97%	(-0.61) 9.91%	(-0.11) 10.51%	(-3.01) 10.65%	(0.01) 13.68%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	41.74%	41.10%	41.54%	42.12%	41.12%	40.81%	36.33%	35.17%	35.00%	35.24%	35.45%	34.73%	35.92%	32.64%
No. of Shareholders	176,506	179,373	184,489	190,655	187,039	196,314	185,111	185,436	189,012	204,122	215,796	226,286	258,239	276,664

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Sales	535	580	425	417	375	530	471	377	393	415	373	356	358	485	472	531	457	460
Sales Growth % (YoY)	42.4%	9.5%	-9.7%	10.6%	-4.6%	27.7%	26.2%	5.9%	9.9%	10.8%	3.8%	-12%	-4%	5.4%	-	-	-	-
Sales Growth % (QoQ)	-7.8%	36.5%	1.9%	11.2%	-29.2%	12.5%	24.9%	-4.1%	-5.3%	11.3%	4.8%	-0.6%	-26.2%	2.8%	-11.1%	16.2%	-0.7%	-
Expenses	398	463	322	343	280	386	356	293	310	307	285	282	281	405	385	441	371	385
Operating Profit	136	117	103	74	95	143	115	85	84	107	88	74	77	80	86	90	86	76
OPM %	25	20	24	18	25	27	24	22	21	26	24	21	21	16	18	17	19	16
Other Income	3	11	-3	3	2	-3	12	3	2	6	0	0	5	1	0	1	0	3
Interest	13	17	13	11	7	6	10	5	4	4	4	4	4	6	5	6	4	5
Depreciation	30	28	29	25	23	21	21	19	18	17	17	16	15	16	16	17	14	14
Profit before tax	96	83	59	42	67	114	96	63	63	91	67	54	62	59	65	69	68	59
Tax %	26	25	25	26	24	22	24	25	25	31	29	22	23	27	27	26	24	18
Net Profit	71	62	44	31	51	89	74	48	47	63	48	42	48	43	48	51	52	49
Net Profit Growth % (QoQ)	14.5%	40.9%	41.9%	-39.2%	-42.7%	20.3%	54.2%	2.1%	-25.4%	31.2%	14.3%	-12.5%	11.6%	-10.4%	-5.9%	-1.9%	6.1%	-
Net Profit Growth % (YoY)	39.2%	-30.3%	-40.5%	-35.4%	8.5%	41.3%	54.2%	14.3%	-2.1%	46.5%	-	-17.6%	-7.7%	-12.2%	-	-	-	-
TTM Net Profit	208	188	215	245	262	258	232	206	200	201	181	181	190	194	200	152	101	0
EPS in Rs	7.86	6.84	4.84	3.41	5.65	9.8	8.11	5.28	5.2	6.95	5.32	4.61	5.26	4.73	5.26	0	0	0

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	1798	1771	1502	1511	941	0	0
Sales Growth %	1.5%	17.9%	-0.6%	60.6%	-	-	-
Expenses	1425	1345	1156	1203	761	0	0
Operating Profit	373	427	346	308	180	0	0
OPM %	21	24	23	20	19	0	0
Other Income	13	14	11	1	3	0	0
Interest	47	26	17	20	11	0	0
Depreciation	104	79	66	56	37	0	0
Profit before tax	234	336	275	233	134	0	0
Tax %	25	23	27	26	20	0	0
Net Profit	176	257	201	172	107	0	0
Net Profit Growth %	-31.5%	27.9%	16.9%	60.7%	-	-	-
EPS in Rs	19.44	28.39	22.14	18.95	0	0	0
Dividend Payout %	18	18	14	11	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	257	340	184	216	-65
Cash from Investing Activity	-425	-420	-184	-116	-134
Cash from Financing Activity	171	79	4	-157	255
Net Cash Flow	3	-1	4	-56	56

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	45	45	45	45	45	45	0.25	0.25	0.25
Reserves	1937	2001	1799	1811	1576	1393	1284	0	0
Borrowings	754	659	411	386	272	208	327	0	0
Other Liabilities	591	561	468	533	404	330	215	0	0
Total Liabilities	3328	3266	2724	2777	2297	1976	1827	0	0
Fixed Assets	1525	1515	1059	1204	953	848	701	0	0
CWIP	305	160	369	116	137	102	187	0	0
Investments	44	187	57	94	62	55	40	0	0
Other Assets	1453	1403	1239	1362	1145	971	898	0	0
Total Assets	3328	3266	2724	2777	2297	1976	1827	0	0

Delivery

Delivery Data: AARTIPHARM

#	Date	765 31% 1002	Value (Cr)	Q/T 48	Del 38	Del 67
1	21-Oct	843	55	16	45	25
2	19-Oct	832	38	15	60	23
3	16-Oct	874	27	14	45	12
4	15-Oct	864	18	13	53	9
5	14-Oct	868	52	16	42	22
6	13-Oct	884	43	17	43	19
7	12-Oct	878	38	15	42	16
8	9-Oct	856	38	14	37	14
9	8-Oct	879	102	17	37	37
10	7-Oct	953	50	14	46	23
11	6-Oct	975	52	15	48	25
12	5-Oct	947	60	17	43	26
13	1-Oct	968	62	18	42	26
14	30-Sep	954	92	17	37	34
15	29-Sep	973	77	19	41	32
16	28-Sep	914	49	18	52	26
17	25-Sep	940	64	20	26	16
18	24-Sep	934	75	19	39	30
19	23-Sep	940	276	25	22	61
20	22-Sep	884	125	23	27	34
21	21-Sep	846	201	61	63	127
22	18-Sep	820	156	85	63	99
23	17-Sep	827	20	11	40	8
24	16-Sep	813	30	13	37	11
25	15-Sep	789	31	15	51	16
26	11-Sep	827	22	12	47	10
27	10-Sep	826	23	13	40	9
28	9-Sep	830	47	18	45	21
29	8-Sep	867	40	20	44	18
30	7-Sep	863	65	26	49	32
31	4-Sep	859	40	24	53	21
32	3-Sep	868	33	21	37	12
33	2-Sep	867	30	17	35	10
34	1-Sep	865	44	21	37	16
35	31-Aug	845	44	20	44	19
36	28-Aug	841	23	18	42	10
37	27-Aug	814	33	19	49	16
38	26-Aug	837	37	18	34	13
39	25-Aug	835	33	25	46	15
40	24-Aug	843	63	23	38	24
41	21-Aug	817	42	19	50	21
42	20-Aug	829	19	15	40	7
43	19-Aug	834	32	18	39	12
44	18-Aug	875	28	18	34	10
45	17-Aug	862	45	21	39	17
46	14-Aug	851	34	21	39	13
47	13-Aug	874	53	31	22	12
48	12-Aug	889	322	33	13	41

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	7,540c	31c	0.41
19-Oct	7,571c	381c	4.80
17-Oct	7,952c	0	0
16-Oct	7,952c	90c	1.15
15-Oct	7,862c	34c	0.43
14-Oct	7,828c	172c	2.15
13-Oct	8,000c	98c	1.23
12-Oct	7,903c	105c	1.35
09-Oct	7,798c	181c	2.26
08-Oct	7,978c	592c	6.90
05-Oct	8,570c	3c	0.04
01-Oct	8,567c	193c	2.31
29-Sep	8,373c	67c	0.81
28-Sep	8,306c	194c	2.28
25-Sep	8,500c	95c	1.10
24-Sep	8,595c	656c	8.26
22-Sep	7,939c	505c	6.79
17-Sep	7,434c	28c	0.37
10-Sep	7,406c	501c	6.33
07-Sep	7,907c	84c	1.07
04-Sep	7,823c	0	0

Stock Checklist

Price is above from 52 week high low average: 59%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 24 fund scheme(s) across 10 fund house(s) as of Oct26 · Total value ₹103 Cr · 10 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
UTI Mutual Fund	2	1.00%	+0.12%	28.6
Motilal Oswal Mutual Fund	4	0.54%	+0.10%	26.7
WhiteOak Capital Mutual Fund	2	1.30%	+0.35%	22.3
HDFC Mutual Fund	2	0.02%	-	12.9
Unifi Mutual Fund	2	1.69%	+0.18%	8.1
Taurus Mutual Fund	2	0.57%	-0.40%	4.4
Groww Mutual Fund	2	0.03%	-	0.2
Bandhan Mutual Fund	4	0.11%	+0.05%	0.1
Mirae Asset Mutual Fund	2	0.02%	-	0
Angel One Mutual Fund	2	0.02%	-	0

Aarti Pharmalabs Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements